Japan lodges complaint against Novartis

Share this article:

Japan is filing a criminal complaint against Novartis and its ads for blood pressure medication Diovan. The Japan Times reports that the health ministry's complaint alleges exaggerated advertising, following a September health ministry finding that the company leveraged information from reports that were later discredited for false claims that the drug reduced the risk of cerebral stroke and angina.

The Japan Times says promotional materials for Diovan cited these reports around 700 times. The drug launched in Japan in 2000. Two universities involved in the studies announced in July 2013 that the data had been manipulated.

Novartis has said that it did not know the data was falsified.

Share this article:
close

Next Article in Business Briefs

Email Newsletters

More in Business Briefs

Illumina inks deal with J&J, AstraZeneca, Sanofi

The goal is to develop companion diagnostics to match patients with cancer treatments.

Abbott deal highlights inversion inaction

Political furor over the recent spate of tax inversions is having little influence on how the government chooses its partners.

Allergan reported to seek out Salix deal

The Wall Street Journal says the deal would add "another layer of intrigue" to the Allergan-Valeant hostilities.